120 related articles for article (PubMed ID: 38042504)
1. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase.
Xu Y; Xu L; Xu C; Zhao M; Xu T; Xia L; Wu Y; Cao Y; Han Z
Brain Res Bull; 2024 Jan; 206():110836. PubMed ID: 38042504
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotection by freezing ischemic penumbra evolution without cerebral blood flow augmentation with a postsynaptic density-95 protein inhibitor.
Bråtane BT; Cui H; Cook DJ; Bouley J; Tymianski M; Fisher M
Stroke; 2011 Nov; 42(11):3265-70. PubMed ID: 21903963
[TBL] [Abstract][Full Text] [Related]
3. Delayed Administration of Tat-HA-NR2B9c Promotes Recovery After Stroke in Rats.
Zhou HH; Tang Y; Zhang XY; Luo CX; Gao LY; Wu HY; Chang L; Zhu DY
Stroke; 2015 May; 46(5):1352-8. PubMed ID: 25851770
[TBL] [Abstract][Full Text] [Related]
4. Lithium upregulates growth-associated protein-43 (GAP-43) and postsynaptic density-95 (PSD-95) in cultured neurons exposed to oxygen-glucose deprivation and improves electrophysiological outcomes in rats subjected to transient focal cerebral ischemia following a long-term recovery period.
Tai SH; Huang SY; Chao LC; Lin YW; Huang CC; Wu TS; Shan YS; Lee AH; Lee EJ
Neurol Res; 2022 Oct; 44(10):870-878. PubMed ID: 35348035
[TBL] [Abstract][Full Text] [Related]
5. Apelin-13 Protects against Ischemic Blood-Brain Barrier Damage through the Effects of Aquaporin-4.
Chu H; Yang X; Huang C; Gao Z; Tang Y; Dong Q
Cerebrovasc Dis; 2017; 44(1-2):10-25. PubMed ID: 28402976
[TBL] [Abstract][Full Text] [Related]
6. Calycosin-7-O-β-D-glucoside regulates nitric oxide /caveolin-1/matrix metalloproteinases pathway and protects blood-brain barrier integrity in experimental cerebral ischemia-reperfusion injury.
Fu S; Gu Y; Jiang JQ; Chen X; Xu M; Chen X; Shen J
J Ethnopharmacol; 2014 Aug; 155(1):692-701. PubMed ID: 24930357
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion.
Hu XM; Zhou MM; Hu XM; Zeng FD
Acta Pharmacol Sin; 2005 Dec; 26(12):1454-9. PubMed ID: 16297343
[TBL] [Abstract][Full Text] [Related]
8. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
[TBL] [Abstract][Full Text] [Related]
9. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
11. Cloning, expression, and purification of a recombinant Tat-HA-NR2B9c peptide.
Zhou HH; Zhang AX; Zhang Y; Zhu DY
Protein Expr Purif; 2012 Oct; 85(2):239-45. PubMed ID: 22944204
[TBL] [Abstract][Full Text] [Related]
12. Tat-NR2B9c prevents excitotoxic neuronal superoxide production.
Chen Y; Brennan-Minnella AM; Sheth S; El-Benna J; Swanson RA
J Cereb Blood Flow Metab; 2015 May; 35(5):739-42. PubMed ID: 25669908
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
[TBL] [Abstract][Full Text] [Related]
14. Selectivity, efficacy and toxicity studies of UCCB01-144, a dimeric neuroprotective PSD-95 inhibitor.
Bach A; Clausen BH; Kristensen LK; Andersen MG; Ellman DG; Hansen PBL; Hasseldam H; Heitz M; Özcelik D; Tuck EJ; Kopanitsa MV; Grant SGN; Lykke-Hartmann K; Johansen FF; Lambertsen KL; Strømgaard K
Neuropharmacology; 2019 May; 150():100-111. PubMed ID: 30836092
[TBL] [Abstract][Full Text] [Related]
15. S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
Khan M; Dhammu TS; Qiao F; Kumar P; Singh AK; Singh I
J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104470. PubMed ID: 31680031
[TBL] [Abstract][Full Text] [Related]
16. Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.
Zhou L; Li F; Xu HB; Luo CX; Wu HY; Zhu MM; Lu W; Ji X; Zhou QG; Zhu DY
Nat Med; 2010 Dec; 16(12):1439-43. PubMed ID: 21102461
[TBL] [Abstract][Full Text] [Related]
17. Contribution of nitric oxide synthase (NOS) activity in blood-brain barrier disruption and edema after acute ischemia/reperfusion in aortic coarctation-induced hypertensive rats.
Mohammadi MT; Shid Moosavi SM; Dehghani GA
Iran Biomed J; 2011; 15(1-2):22-30. PubMed ID: 21725496
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Benefits of Adropin in Aged Mice After Transient Ischemic Stroke via Reduction of Blood-Brain Barrier Damage.
Yang C; Liu L; Lavayen BP; Larochelle J; Gunraj RE; Butler AA; Candelario-Jalil E
Stroke; 2023 Jan; 54(1):234-244. PubMed ID: 36305313
[TBL] [Abstract][Full Text] [Related]
19. [Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats].
Ni C; Zeng N; Xu F; Gou L; Liu J; Wang J; Xia H
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2562-6. PubMed ID: 22256767
[TBL] [Abstract][Full Text] [Related]
20. PDZ protein interactions underlying NMDA receptor-mediated excitotoxicity and neuroprotection by PSD-95 inhibitors.
Cui H; Hayashi A; Sun HS; Belmares MP; Cobey C; Phan T; Schweizer J; Salter MW; Wang YT; Tasker RA; Garman D; Rabinowitz J; Lu PS; Tymianski M
J Neurosci; 2007 Sep; 27(37):9901-15. PubMed ID: 17855605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
